<GlossaryTerm id="CDR0000601031"><TermName>Elspar</TermName><TermPronunciation>(EL-spar)</TermPronunciation><TermDefinition><DefinitionText>A drug that is used to treat acute lymphoblastic leukemia (ALL) and is being studied in the treatment of some other types of cancer. It is an enzyme taken from the bacterium Escherichia coli (E. coli). It breaks down the amino acid asparagine and may block the growth of tumor cells that need asparagine to grow. Also called asparaginase and L-asparaginase.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000720823" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Elspar&quot;" language="en" id="_3"/><MediaLink ref="CDR0000720822" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Elspar&quot;" language="es" id="_4"/><SpanishTermName>Elspar</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar la leucemia linfoblástica aguda (LLA) y que está en estudio para el tratamiento de algunos otros tipos de cáncer. Es una enzima que se toma de la bacteria Escherichia coli (E. coli). Descompone el aminoácido asparagina y puede impedir la formación de las células tumorales que necesitan asparagina para crecer. También se llama asparaginasa y L-asparaginasa.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-07-15</DateFirstPublished><DateLastModified>2008-07-15</DateLastModified></GlossaryTerm>
